Clinical trial
Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2…
NCT00399204 · Post Graduate Institute of Medical Education and Research, Chandigarh, Other · Withdrawn
Key facts
| NCT number | NCT00399204 |
|---|---|
| Title | Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients |
| Official title | A Randomised Pilot Study to Compare the Effect of Pioglitazone and Metformin on Cardiovascular Morbidity and Mortality in Patients With Type 2 Diabetes |
| Lead sponsor | Post Graduate Institute of Medical Education and Research, Chandigarh, Other |
| Collaborators | Council of Scientific and Industrial Research, India |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Pioglitazone vs Metformin |
| Enrollment | 0 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Nov 14, 2006 |
| Last update posted | Mar 20, 2019 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: